TerrAscend Resultados de beneficios anteriores
Pasado controles de criterios 0/6
TerrAscend ha aumentado sus beneficios a una tasa media anual de 19%, mientras que los beneficios de la industria de Pharmaceuticals han experimentado un crecimiento anual de 30.5%. Los ingresos han ido creciendo a una tasa media de 7.1% al año.
Información clave
19.02%
Tasa de crecimiento de los beneficios
26.11%
Tasa de crecimiento del BPA
| Crecimiento de la industria Pharmaceuticals | 23.06% |
| Tasa de crecimiento de los ingresos | 7.13% |
| Rentabilidad financiera | -32.49% |
| Margen neto | -12.04% |
| Última actualización de beneficios | 30 Jun 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Actualización de narrativa • Jul 02
TSND: Uplisting Preparations And New Jersey Dispensary Deal Will Support Upside
Analysts have lifted their CA$ price target on TerrAscend, reflecting a revised fair value estimate of CA$1.50. This figure is supported by updated assumptions for revenue growth, profit margins, and future P/E levels.
Actualización de narrativa • Jun 18
TSND: Expanding M&A Pipeline And New Leadership Will Support Future Profitability
Analysts have nudged their fair value price target for TerrAscend to CA$2.01. This reflects updated assumptions for discount rate, revenue growth, profit margin and future P/E that slightly adjust how they frame the stock’s risk and earnings potential.Actualización de narrativa • Jun 03
TSND: Active M&A Agenda And Margin Improvements Will Support Future Profitability
Analysts have adjusted their TerrAscend price target to CA$2.01 from CA$2.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News TerrAscend reiterated an active M&A agenda, with executives highlighting ongoing discussions for accretive acquisitions and interest in distressed assets in core markets, sourced from the first quarter 2026 results call.Actualización de narrativa • May 07
TSND: Expanded Retail Footprint And Margin Gains Will Support Future Profitability
Analysts have nudged their TerrAscend price target slightly higher to CA$2.00 from CA$2.00, citing updated assumptions around revenue growth, profit margins and a lower future P/E multiple that together support a modestly improved valuation outlook. What's in the News TerrAscend issued earnings guidance for the first quarter of 2026, anticipating net revenue of $65.5 million, compared with $66.1 million in the fourth quarter of 2025 and $64.3 million in the first quarter of 2025 (Key Developments).Actualización de narrativa • Apr 18
TSND: New CFO Hire And Share Buyback Will Support Future Upside
Analysts have modestly adjusted their price target on TerrAscend, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. Together, these factors refine their view of what the shares could be worth in CA$ terms.Actualización de narrativa • Apr 04
TSND: New Brand Partnership And Share Buyback Will Support Future Upside
Analysts have nudged their TerrAscend price target modestly higher to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News TerrAscend announced the official launch of TYSON 2.0 products in Pennsylvania and Maryland, covering premium flower and high potency vape products under its exclusive partnership with the brand (Key Developments).Actualización de narrativa • Mar 20
TSND: Expanded New Jersey Retail Footprint Will Support Future Profitability
Analysts have slightly adjusted their CA$ price target on TerrAscend, citing updated assumptions for revenue growth, profit margins, and a modest change in the expected future P/E multiple. What's in the News TerrAscend completed a share buyback tranche between October 1, 2025 and December 31, 2025, repurchasing 75,000 shares for $0.03m, equal to 0.02% of shares under the program first announced on August 20, 2025 (Key Developments).Actualización de narrativa • Mar 04
TSND: Expanded New Jersey Footprint Will Support Future Profitability
Analysts have nudged their TerrAscend price target slightly higher to CA$2.00 from about CA$1.98, citing updated assumptions that include a modestly adjusted discount rate, changes to revenue growth and profit margin expectations, and a higher future P/E estimate. What's in the News TerrAscend closed its previously announced transaction with Union Chill Cannabis Company LLC, a dispensary operator in Hunterdon County, New Jersey.Actualización de narrativa • Feb 18
TSND: Union Chill Expansion Will Support Future Retail Scale And Margins
Analysts have trimmed their CA$ price target for TerrAscend, citing a slightly higher discount rate, a modestly reduced revenue outlook, and an improved profit margin profile that together reset expectations around the stock's future P/E level. What's in the News Closed the previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing Hunterdon County dispensary and bringing TerrAscend's New Jersey retail footprint to four locations (Key Developments).Artículo de análisis • Feb 12
More Unpleasant Surprises Could Be In Store For TerrAscend Corp.'s (TSE:TSND) Shares After Tumbling 27%
TerrAscend Corp. ( TSE:TSND ) shares have had a horrible month, losing 27% after a relatively good period beforehand...Actualización de narrativa • Feb 04
TSND: Union Chill Deal Will Drive Future Retail And Margin Upside
Analysts have trimmed their price target on TerrAscend to about US$1.25 from roughly US$1.50, citing reduced revenue growth expectations and a lower future P/E multiple, partly offset by higher projected profit margins. What's in the News TerrAscend closed its previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing dispensary in Hunterdon County, New Jersey, and bringing its retail footprint in the state to four dispensaries (Key Developments).Actualización de narrativa • Jan 21
TSND: Expanded Retail Footprint And Licensing Will Support Future Profitability
Analysts have modestly revised their price target on TerrAscend, citing slightly firmer profit margin expectations and a small adjustment to revenue trends and future P/E assumptions. Together, these factors support a refined fair value estimate without a material change in the overall valuation level.Actualización de narrativa • Jan 06
TSND: Expanded Mid Atlantic Footprint And Licensing Will Support Higher Profitability
Analysts have nudged their price target on TerrAscend toward about $2.00, reflecting updated views that incorporate higher projected profit margins, a lower assumed future P/E multiple near 43, and adjusted revenue expectations. What's in the News Closed the previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing dispensary in Hunterdon County and bringing TerrAscend's New Jersey retail footprint to four dispensaries (Key Developments).Actualización de narrativa • Dec 15
TSND: Licensing Expansion Into Mid Atlantic Markets Will Drive Stronger Profitability
Analysts have raised their price target on TerrAscend by approximately $2.25 to about $1.98 per share. They cited expectations for stronger profit margins and a more reasonable future earnings multiple, even as they moderate revenue growth assumptions and apply a slightly higher discount rate.Artículo de análisis • Dec 14
TerrAscend Corp.'s (TSE:TSND) Shares Climb 123% But Its Business Is Yet to Catch Up
TerrAscend Corp. ( TSE:TSND ) shares have had a really impressive month, gaining 123% after a shaky period beforehand...Artículo de análisis • Nov 09
Earnings Release: Here's Why Analysts Cut Their TerrAscend Corp. (TSE:TSND) Price Target To CA$1.75
TerrAscend Corp. ( TSE:TSND ) shareholders are probably feeling a little disappointed, since its shares fell 4.0% to...Artículo de análisis • Oct 30
TerrAscend Corp.'s (TSE:TSND) 27% Share Price Plunge Could Signal Some Risk
The TerrAscend Corp. ( TSE:TSND ) share price has softened a substantial 27% over the previous 30 days, handing back...Artículo de análisis • Jun 11
Some TerrAscend Corp. (TSE:TSND) Shareholders Look For Exit As Shares Take 34% Pounding
Unfortunately for some shareholders, the TerrAscend Corp. ( TSE:TSND ) share price has dived 34% in the last thirty...Artículo de análisis • Apr 27
TerrAscend Corp. (TSE:TSND) Shares May Have Slumped 30% But Getting In Cheap Is Still Unlikely
The TerrAscend Corp. ( TSE:TSND ) share price has fared very poorly over the last month, falling by a substantial 30...
Nueva narrativa • Apr 02
ERP Implementation And Ohio Expansion Will Improve Operational Efficiency
Strategic expansions into new markets like Ohio and New Jersey are poised to enhance revenue and profitability through streamlined operations and vertical integration.Artículo de análisis • Mar 05
With A 29% Price Drop For TerrAscend Corp. (TSE:TSND) You'll Still Get What You Pay For
To the annoyance of some shareholders, TerrAscend Corp. ( TSE:TSND ) shares are down a considerable 29% in the last...Artículo de análisis • Jan 03
These 4 Measures Indicate That TerrAscend (TSE:TSND) Is Using Debt Extensively
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Artículo de análisis • Sep 03
Is TerrAscend (TSE:TSND) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Artículo de análisis • Apr 25
TerrAscend (TSE:TSND) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Artículo de análisis • Mar 10
What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash
The TerrAscend Corp. ( TSE:TSND ) share price has softened a substantial 25% over the previous 30 days, handing back...Artículo de análisis • Jan 24
Revenues Tell The Story For TerrAscend Corp. (TSE:TSND) As Its Stock Soars 25%
TerrAscend Corp. ( TSE:TSND ) shareholders would be excited to see that the share price has had a great month, posting...Artículo de análisis • Dec 25
Is TerrAscend (TSE:TSND) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • Aug 13
TerrAscend (TSE:TSND) Is Carrying A Fair Bit Of Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Desglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero TerrAscend. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 26 | 264 | -32 | 88 | 0 |
| 31 Mar 26 | 262 | -28 | 87 | 0 |
| 31 Dec 25 | 261 | -29 | 86 | 0 |
| 30 Sep 25 | 299 | -71 | 107 | 0 |
| 30 Jun 25 | 300 | -77 | 110 | 0 |
| 31 Mar 25 | 263 | -26 | 91 | 0 |
| 31 Dec 24 | 268 | -28 | 91 | 0 |
| 30 Sep 24 | 288 | -81 | 96 | 0 |
| 30 Jun 24 | 312 | -74 | 101 | 0 |
| 31 Mar 24 | 317 | -81 | 109 | 0 |
| 31 Dec 23 | 251 | -36 | 84 | 0 |
| 30 Sep 23 | 300 | -50 | 121 | 0 |
| 30 Jun 23 | 277 | -342 | 119 | 0 |
| 31 Mar 23 | 269 | -311 | 122 | 0 |
| 31 Dec 22 | 248 | -304 | 116 | 0 |
| 30 Sep 22 | 212 | -298 | 94 | 0 |
| 30 Jun 22 | 195 | 59 | 88 | 0 |
| 31 Mar 22 | 189 | 13 | 76 | 0 |
| 31 Dec 21 | 194 | 13 | 75 | 0 |
| 30 Sep 21 | 211 | -96 | 88 | 0 |
| 30 Jun 21 | 200 | -165 | 80 | 0 |
| 31 Mar 21 | 175 | -144 | 73 | 0 |
| 31 Dec 20 | 132 | -125 | 61 | 0 |
| 30 Sep 20 | 118 | -159 | 54 | 1 |
| 30 Jun 20 | 99 | -156 | 55 | 1 |
| 31 Mar 20 | 75 | -155 | 49 | 1 |
| 31 Dec 19 | 64 | -161 | 46 | 1 |
| 30 Sep 19 | 48 | -44 | 41 | 0 |
| 30 Jun 19 | 30 | -33 | 32 | 0 |
| 31 Mar 19 | 16 | -23 | 25 | 0 |
| 31 Dec 18 | 5 | -16 | 17 | 0 |
| 30 Sep 18 | 1 | -9 | 12 | 0 |
| 30 Jun 18 | 0 | -8 | 7 | 0 |
| 31 Mar 18 | 0 | -7 | 6 | 0 |
| 31 Dec 17 | 0 | -5 | 5 | 0 |
| 30 Sep 17 | 0 | -5 | 4 | 0 |
| 30 Jun 17 | 0 | -4 | 3 | 0 |
| 31 Mar 17 | 0 | -1 | 1 | 0 |
| 31 Dec 16 | 0 | -1 | 1 | 0 |
Ingresos de calidad: TSND actualmente no es rentable.
Margen de beneficios creciente: TSND actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: TSND no es rentable, pero ha reducido pérdidas en los últimos 5 años a un ritmo de 19% por año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de TSND en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: TSND no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Pharmaceuticals (233.9%).
Rentabilidad financiera
Alta ROE: TSND tiene una rentabilidad financiera negativa (-32.49%), ya que actualmente no es rentable.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/08/09 04:31 |
| Precio de las acciones al final del día | 2026/08/07 00:00 |
| Beneficios | 2026/06/30 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
TerrAscend Corp. está cubierta por 9 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Frederico Yokota Choucair Gomes | ATB Cormark |
| Matt Bottomley | Canaccord Genuity |
| Shaan Mir | Canaccord Genuity |